Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (proact)

HIGHLIGHTS

  • who: Rebecca H Maier u200d and colleagues from the Data cleaning and analysis will be provided by staff within Newcastle Clinical Trials Unit and Durham UniversityPrimary analysis will follow intention to treat principles with patient data analysed according to randomisation and irrespective of intervention received have published the Article: Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT), in the Journal: BMJ Open 2022;12:e066252. of /2022/
  • what: The trial aims to recruit 106 participants, who will be randomised to standard care (high-u00addose anthracycline-u00ad . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?